- Home
- BATRK vs ALVO Comparison
BATRK vs ALVO Comparison
Compare BATRK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRK
- ALVO
- Stock Information
- Founded
- BATRK 1991
- ALVO 2013
- Country
- BATRK United States
- ALVO Luxembourg
- Employees
- BATRK N/A
- ALVO N/A
- Industry
- BATRK Broadcasting
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- BATRK Industrials
- ALVO Health Care
- Exchange
- BATRK Nasdaq
- ALVO Nasdaq
- Market Cap
- BATRK 2.9B
- ALVO 2.5B
- IPO Year
- BATRK N/A
- ALVO N/A
- Fundamental
- Price
- BATRK $41.63
- ALVO $7.93
- Analyst Decision
- BATRK Strong Buy
- ALVO
- Analyst Count
- BATRK 3
- ALVO 0
- Target Price
- BATRK $58.00
- ALVO N/A
- AVG Volume (30 Days)
- BATRK 303.3K
- ALVO 311.4K
- Earning Date
- BATRK 11-05-2025
- ALVO 11-12-2025
- Dividend Yield
- BATRK N/A
- ALVO N/A
- EPS Growth
- BATRK N/A
- ALVO N/A
- EPS
- BATRK N/A
- ALVO 0.22
- Revenue
- BATRK $702,443,000.00
- ALVO $562,478,000.00
- Revenue This Year
- BATRK $14.16
- ALVO $36.61
- Revenue Next Year
- BATRK $3.97
- ALVO $42.26
- P/E Ratio
- BATRK N/A
- ALVO $36.60
- Revenue Growth
- BATRK 6.51
- ALVO 82.19
- 52 Week Low
- BATRK $35.46
- ALVO $7.35
- 52 Week High
- BATRK $47.18
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- BATRK 32.73
- ALVO 41.12
- Support Level
- BATRK $41.25
- ALVO $7.86
- Resistance Level
- BATRK $42.56
- ALVO $8.15
- Average True Range (ATR)
- BATRK 0.68
- ALVO 0.19
- MACD
- BATRK -0.15
- ALVO 0.01
- Stochastic Oscillator
- BATRK 9.36
- ALVO 13.67
About BATRK Atlanta Braves Holdings Inc. Series C
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.